Interacting Drugs |
Aliskiren and amlodipine vs CYP1A2 Substrates |
Security Level |
 |
Mechanism |
CYP1A2 Substrates: CYP1A2 Inhibitors (Moderate) may decrease the metabolism of CYP1A2 Substrates. |
Management |
Monitor therapy |
Aliskiren and amlodipine vs CYP1A2 Substrates
Post Review about Aliskiren and amlodipine vs CYP1A2 Substrates Click here to cancel reply.
Other Interactions of Aliskiren and amlodipine
Other Interactions of CYP1A2 Substrates
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.